INTERNATIONAL PATENT: ARROWHEAD PHARMACEUTICALS, INC. FILES APPLICATION FOR "RNAI AGENTS FOR INHIBITING EXPRESSION OF MICROTUBULE ASSOCIATED PROTEIN TAU (MAPT), COMPOSITIONS THEREOF AND METHODS OF USE"

GENEVA, Oct. 15 -- ARROWHEAD PHARMACEUTICALS, INC. (177 East Colorado BoulevardSuite 700Pasadena, California 91105) filed a patent application (PCT/US2025/022218) for "RNAI AGENTS FOR INHIBITING EXPRESSION OF MICROTUBULE ASSOCIATED PROTEIN TAU (MAPT), COMPOSITIONS THEREOF, AND METHODS OF USE" on Mar 30, 2025. With publication no. WO/2025/212467, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LAZZARA, Phillip (Arrowhead Pharmaceuticals, Inc.502 S. Rosa RoadMadison, Wisconsin 53719), SUK, Ji Young (Neurocrine Biosciences, ...